Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 16
2022 17
2023 11
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean marco rubattu (2 results)?
A retrospective observational study on cutaneous adverse events induced by immune checkpoint inhibitors.
Medri M, Savoia F, Foca F, Miserocchi A, Quaglino P, Rubatto M, Gullo G, Nardini C, Panasiti V, DE Tursi M, DI Marino P, Brancaccio G, Giunta EF, Napolitano S, Cinotti E, Brusasco M, Stanganelli I; IMI, Italian Melanoma Intergroup. Medri M, et al. Among authors: rubatto m. Ital J Dermatol Venerol. 2023 Dec;158(6):437-444. doi: 10.23736/S2784-8671.23.07542-4. Ital J Dermatol Venerol. 2023. PMID: 38015482 Free article.
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
Mandalà M, Palmieri G, Ludovini V, Baglivo S, Marasciulo F, Castiglione F, Gili A, Osella Abate S, Rubatto M, Senetta R, Avallone G, Ribero S, Romano L, Pimpinelli N, de Giorgi V, Roila F, Pisano M, Casula M, Manca A, Sini MC, Massi D, Quaglino P; Italian Melanoma Intergroup (IMI). Mandalà M, et al. Among authors: rubatto m. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):1991-1998. doi: 10.1111/jdv.19281. Epub 2023 Jun 27. J Eur Acad Dermatol Venereol. 2023. PMID: 37335879
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy.
Rubatto M, Gelato F, Broganelli P, Fava P, Senetta R, Avallone G, Mastorino L, Grandinetti D, Ribero S, Quaglino P. Rubatto M, et al. Ital J Dermatol Venerol. 2023 Apr;158(2):153-154. doi: 10.23736/S2784-8671.22.07329-7. Ital J Dermatol Venerol. 2023. PMID: 37153950 No abstract available.
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Rubatto M, Fava P, Stanganelli I, Ribero S, Pigozzo J, Di Giacomo AM, Ridolfi L, Tronconi MC, Trojaniello C, Bersanelli M, Garutti M, Indini A, De Risi I, De Tursi M, Merelli B, Morgese F, Occelli M, Cappellini GCA, Poletto S, Fedele D, Brugnara S, Frisinghelli M, Formisano L, Conca R, Tucci M, Russillo M, Ceroni L, Queirolo P, Targato G, Strippoli S, Mandalà M, Guida M, Quaglino P. Rubatto M, et al. Eur J Cancer. 2023 Jul;187:25-35. doi: 10.1016/j.ejca.2023.03.020. Epub 2023 Mar 23. Eur J Cancer. 2023. PMID: 37099946
Regression of human papillomavirus-associated high-grade vaginal intraepithelial neoplasia after switching from ustekinumab to risankizumab in a psoriasis patient.
Avallone G, Dapavo P, Cabutti F, Preti M, Cavallo F, Roccuzzo G, Mastorino L, Rubatto M, Quaglino P, Ribero S. Avallone G, et al. Among authors: rubatto m. Ital J Dermatol Venerol. 2023 Feb;158(1):61-62. doi: 10.23736/S2784-8671.22.07297-8. Ital J Dermatol Venerol. 2023. PMID: 36939503 No abstract available.
Advanced Cutaneous Squamous Cell Carcinoma: Italian Multicentric Retrospective Analysis of Patient Profiles and Therapeutic Approaches.
Mannino M, Piccerillo A, Dika E, Vaccari S, Quaglino P, Rubatto M, Longo C, Borsari S, Pellacani G, Fargnoli MC, Caponio C, Argenziano G, Briatico G, Bianchi L, Di Raimondo C, Calzavara Pinton PG, Zalaudek I, Di Stefani A, Peris K. Mannino M, et al. Among authors: rubatto m. Dermatology. 2023;239(3):422-428. doi: 10.1159/000528555. Epub 2023 Mar 15. Dermatology. 2023. PMID: 36921583
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish Report.
Placzke J, Teterycz P, Quaglino P, Cybulska-Stopa B, Tucci M, Rubatto M, Skora T, Interno V, Rosinska M, Borkowska A, Szumera-Cieckiewicz A, Mandala M, Rutkowski P. Placzke J, et al. Among authors: rubatto m. Cancers (Basel). 2022 Nov 23;14(23):5763. doi: 10.3390/cancers14235763. Cancers (Basel). 2022. PMID: 36497248 Free PMC article.
41 results